FOXC1
Forkhead box protein C1
Also known as: ARA, FKHL7, FOXC1_HUMAN, FREAC3, IGDA, IHG1, IRID1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q12948
- Gene
- FOXC1
- Ensembl
- ENSG00000054598
- Chromosome
- 6
- Canonical length
- 553 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain. The specific function of this gene has not yet been determined; however, it has been shown to play a role in the regulation of embryonic and ocular development. Mutations in this gene cause various glaucoma phenotypes including primary congenital glaucoma, autosomal dominant iridogoniodysgenesis anomaly, and Axenfeld-Rieger anomaly. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
553 residues, UniProt reviewed canonical sequence.
>Q12948|FOXC1
1 MQARYSVSSP NSLGVVPYLG GEQSYYRAAA AAAGGGYTAM PAPMSVYSHP AHAEQYPGGM
61 ARAYGPYTPQ PQPKDMVKPP YSYIALITMA IQNAPDKKIT LNGIYQFIMD RFPFYRDNKQ
121 GWQNSIRHNL SLNECFVKVP RDDKKPGKGS YWTLDPDSYN MFENGSFLRR RRRFKKKDAV
181 KDKEEKDRLH LKEPPPPGRQ PPPAPPEQAD GNAPGPQPPP VRIQDIKTEN GTCPSPPQPL
241 SPAAALGSGS AAAVPKIESP DSSSSSLSSG SSPPGSLPSA RPLSLDGADS APPPPAPSAP
301 PPHHSQGFSV DNIMTSLRGS PQSAAAELSS GLLASAAASS RAGIAPPLAL GAYSPGQSSL
361 YSSPCSQTSS AGSSGGGGGG AGAAGGAGGA GTYHCNLQAM SLYAAGERGG HLQGAPGGAG
421 GSAVDDPLPD YSLPPVTSSS SSSLSHGGGG GGGGGGQEAG HHPAAHQGRL TSWYLNQAGG
481 DLGHLASAAA AAAAAGYPGQ QQNFHSVREM FESQRIGLNN SPVNGNSSCQ MAFPSSQSLY
541 RTSGAFVYDC SKFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FOXC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 146 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 146 nTPM
- blood vessel: 80 nTPM
- kidney: 18 nTPM
- heart muscle: 13 nTPM
- adipose tissue: 12 nTPM
- skin: 10 nTPM
Single-cell type
- lacrimal acinar cells: 389 nCPM
- salivary acinar cells: 329 nCPM
- salivary basal cells: 221 nCPM
- salivary duct cells: 205 nCPM
- podocytes: 202 nCPM
- salivary myoepithelial cells: 167 nCPM
Immune cell
- NK-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- choroid plexus: 18 nTPM
- thalamus: 14 nTPM
- medulla oblongata: 14 nTPM
- pons: 14 nTPM
- basal ganglia: 12 nTPM
- amygdala: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FOXC1.
Disease | AllUniProt
Conditions FOXC1 is implicated in, by any mechanism.
- Axenfeld-Rieger syndrome 3 (RIEG3) MIM:602482
- Anterior segment dysgenesis 3 (ASGD3) MIM:601631
Disease | GeneticClinVar
156 pathogenic / likely-pathogenic of 780 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Axenfeld-Rieger syndrome type 3
- Anterior segment dysgenesis 3
- FOXC1-related disorder
- Anterior segment dysgenesis
- Congenital anomaly of kidney and urinary tract
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.95
- gnomAD missense Z
- 0.34
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anatomical structure morphogenesis
- angiogenesis
- apoptotic process involved in outflow tract morphogenesis
- artery morphogenesis
- blood vessel diameter maintenance
- blood vessel remodeling
- camera-type eye development
- cardiac muscle cell proliferation
- cell differentiation
- cell migration
- cell population proliferation
- cellular response to chemokine
- cellular response to epidermal growth factor stimulus
- cerebellum development
- chemokine-mediated signaling pathway
- collagen fibril organization
- embryonic heart tube development
- endochondral ossification
- eye development
- germ cell migration
- glycosaminoglycan metabolic process
- heart development
- in utero embryonic development
- kidney development
- lacrimal gland development
- lymph vessel development
- maintenance of lens transparency
- mesenchymal cell development
- negative regulation of angiogenesis
- negative regulation of apoptotic process involved in outflow tract morphogenesis
- negative regulation of lymphangiogenesis
- negative regulation of mitotic cell cycle
- negative regulation of transcription by RNA polymerase II
- neural crest cell development
- Notch signaling pathway
- odontogenesis of dentin-containing tooth
- ovarian follicle development
- paraxial mesoderm formation
- positive regulation of core promoter binding
- positive regulation of DNA binding
- positive regulation of DNA-templated transcription
- positive regulation of epithelial to mesenchymal transition
- positive regulation of gene expression
- positive regulation of hematopoietic progenitor cell differentiation
- positive regulation of keratinocyte differentiation
- positive regulation of transcription by RNA polymerase II
- regulation of DNA-templated transcription
- regulation of organ growth
- regulation of transcription by RNA polymerase II
- somitogenesis
- ureteric bud development
- vascular endothelial growth factor receptor signaling pathway
- vascular endothelial growth factor signaling pathway
- ventricular cardiac muscle tissue morphogenesis
- glomerular epithelium development
- positive regulation of hematopoietic stem cell differentiation
Molecular functions
- DNA binding
- DNA binding, bending
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor binding
- promoter-specific chromatin binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific DNA binding
- transcription cis-regulatory region binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FOXC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FOXC1 as an antibody target. Whether an autoantibody or antibody against FOXC1 could matter depends on whether native FOXC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FOXC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FOXC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...